MedPath

University Hospital Antwerp

University Hospital Antwerp logo
πŸ‡§πŸ‡ͺBelgium
Ownership
Private
Established
1979-01-01
Employees
1K
Market Cap
-
Website
http://www.uza.be

Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase 2
Completed
Conditions
Non-Small Cell Lung Cancer
Interventions
Drug: combination chemotherapy (pemetrexed + cisplatin)
Radiation: thoracic irradiation + pemetrexed
First Posted Date
2007-07-06
Last Posted Date
2009-04-10
Lead Sponsor
University Hospital, Antwerp
Target Recruit Count
30
Registration Number
NCT00497315
Locations
πŸ‡§πŸ‡ͺ

University Hospital Antwerp, Edegem, Antwerp, Belgium

πŸ‡§πŸ‡ͺ

St Augustinus Ziekenhuis, Wilrijk, Antwerp, Belgium

πŸ‡§πŸ‡ͺ

ZNA Middelheim, Antwerpen, Antwerp, Belgium

Intracoronary Infusion of BM-Derived Mononuclear Cells in Patients With Large Acute Myocardial Infarction

Phase 2
Conditions
Myocardial Infarction
First Posted Date
2007-07-06
Last Posted Date
2007-07-06
Lead Sponsor
University Hospital, Antwerp
Registration Number
NCT00497211
Locations
πŸ‡§πŸ‡ͺ

Universitair Ziekenhuis Antwerpen, Edegem, Belgium

A Combined Surgical and Medical Approach in Mild Sleep Apnea

Not Applicable
Conditions
Sleep Apnea
First Posted Date
2007-07-06
Last Posted Date
2007-07-06
Lead Sponsor
University Hospital, Antwerp
Registration Number
NCT00497120
Locations
πŸ‡§πŸ‡ͺ

University Hospital Antwerp, Edegem, Antwerp, Belgium

Fibrosis in Renal Allografts

Phase 4
Conditions
Kidney Failure, Chronic
Transplantation
Immunosuppression
Interstitial Fibrosis
First Posted Date
2007-06-28
Last Posted Date
2008-11-26
Lead Sponsor
University Hospital, Antwerp
Target Recruit Count
100
Registration Number
NCT00493194
Locations
πŸ‡§πŸ‡ͺ

University Hospital Gent, Gent, Oost-Vlaanderen, Belgium

πŸ‡§πŸ‡ͺ

University Hospital Brussels, Brussels (Jette), Brabant, Belgium

πŸ‡§πŸ‡ͺ

University Hospital Antwerp, Edegem, Antwerp, Belgium

Blood Endothelium Progenitor Cells and Dendritic Cells as Predictive Biomarkers of In-stent Restenosis

Completed
Conditions
Restenosis
Atherosclerosis
First Posted Date
2007-06-28
Last Posted Date
2022-11-04
Lead Sponsor
University Hospital, Antwerp
Target Recruit Count
124
Registration Number
NCT00493597
Locations
πŸ‡§πŸ‡ͺ

Universitair Ziekenhuis Antwerpen, Edegem, Antwerpen, Belgium

Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC

Phase 2
Completed
Conditions
Non-Small-Cell-Lung Cancer
First Posted Date
2007-04-20
Last Posted Date
2013-07-12
Lead Sponsor
University Hospital, Antwerp
Target Recruit Count
77
Registration Number
NCT00463515
Locations
πŸ‡§πŸ‡ͺ

ZNA Middelheim, Antwerpen, Antwerp, Belgium

πŸ‡§πŸ‡ͺ

Sint Augustinus Ziekenhuis, Wilrijk, Antwerp, Belgium

πŸ‡§πŸ‡ͺ

University Hospital Antwerp, Edegem, Antwerp, Belgium

Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely Resected Stage IB/II Non-Small Cell Lung Cancer

Phase 2
Completed
Conditions
Non-small Cell Lung Cancer
First Posted Date
2007-02-13
Last Posted Date
2010-11-30
Lead Sponsor
University Hospital, Antwerp
Target Recruit Count
99
Registration Number
NCT00434668
Locations
πŸ‡§πŸ‡ͺ

University Hospital Antwerp, Edegem, Antwerp, Belgium

πŸ‡§πŸ‡ͺ

ZNA Middelheim, Antwerpen, Antwerp, Belgium

πŸ‡§πŸ‡ͺ

St Augustinus ziekenhuis, Wilrijk, Antwerp, Belgium

Effectiveness of Influenza Vaccination Among General Practitioners

Phase 4
Completed
Conditions
Influenza
First Posted Date
2005-09-22
Last Posted Date
2006-11-28
Lead Sponsor
University Hospital, Antwerp
Target Recruit Count
300
Registration Number
NCT00221676
Β© Copyright 2025. All Rights Reserved by MedPath